Loading…
Lobbying Spend
—
Filings
22
Firms Hired
1
Active Period
2019–2023
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Protecting Health Care for All Patients Act of 2023
2023 · fourth_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Implementation of the Inflation Reduction Act - Public Law No 117-69. H.R. 485 - the Protecting Health Care for All Patients Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 485
Protecting Health Care for All Patients Act of 2023
2023 · fourth_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 485
Ensuring Timely Access to Generics Act of 2023
2023 · fourth_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 1067
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 1214
Affordable Prescriptions for Patients Act of 2023
2023 · fourth_quarter · Firm: MCDERMOTT+ LLC
Patent abuse issues. S. 150 - Affordable Prescriptions for Patients Act of 2023. S. 79 - Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives.
Client expense: — · Firm income: $30,000
Matched citations: S. 150
Increasing Transparency in Generic Drug Applications Act
2023 · fourth_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 775
Interagency Patent Coordination and Improvement Act of 2023
2023 · fourth_quarter · Firm: MCDERMOTT+ LLC
Patent abuse issues. S. 150 - Affordable Prescriptions for Patients Act of 2023. S. 79 - Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives.
Client expense: — · Firm income: $30,000
Matched citations: S. 79
Fair Accountability and Innovative Research Drug Pricing Act of 2023
2023 · fourth_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 935
Protecting Health Care for All Patients Act of 2023
2023 · third_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 485
Protecting Health Care for All Patients Act of 2023
2023 · third_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Implementation of the Inflation Reduction Act - Public Law No 117-69. H.R. 485 - the Protecting Health Care for All Patients Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 485
Ensuring Timely Access to Generics Act of 2023
2023 · third_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 1067
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 1214
Affordable Prescriptions for Patients Act of 2023
2023 · third_quarter · Firm: MCDERMOTT+ LLC
Patent abuse issues. S. 150 - Affordable Prescriptions for Patients Act of 2023. S. 79 - Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives.
Client expense: — · Firm income: $30,000
Matched citations: S. 150
Increasing Transparency in Generic Drug Applications Act
2023 · third_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 775
Interagency Patent Coordination and Improvement Act of 2023
2023 · third_quarter · Firm: MCDERMOTT+ LLC
Patent abuse issues. S. 150 - Affordable Prescriptions for Patients Act of 2023. S. 79 - Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives.
Client expense: — · Firm income: $30,000
Matched citations: S. 79
Fair Accountability and Innovative Research Drug Pricing Act of 2023
2023 · third_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 935
Protecting Health Care for All Patients Act of 2023
2023 · second_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Implementation of the Inflation Reduction Act - Public Law No 117-69. H.R. 485 - the Protecting Health Care for All Patients Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 485
Protecting Health Care for All Patients Act of 2023
2023 · second_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 485
Ensuring Timely Access to Generics Act of 2023
2023 · second_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 1067
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 1214
Affordable Prescriptions for Patients Act of 2023
2023 · second_quarter · Firm: MCDERMOTT+ LLC
Patent abuse issues. S. 150 - Affordable Prescriptions for Patients Act of 2023. S. 79 - Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives. Notice of Public Listening Session and Request for Comment (PTO-P-2022-0037).
Client expense: — · Firm income: $30,000
Matched citations: S. 150
Increasing Transparency in Generic Drug Applications Act
2023 · second_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 775
Interagency Patent Coordination and Improvement Act of 2023
2023 · second_quarter · Firm: MCDERMOTT+ LLC
Patent abuse issues. S. 150 - Affordable Prescriptions for Patients Act of 2023. S. 79 - Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives. Notice of Public Listening Session and Request for Comment (PTO-P-2022-0037).
Client expense: — · Firm income: $30,000
Matched citations: S. 79
Fair Accountability and Innovative Research Drug Pricing Act of 2023
2023 · second_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act. S. 775 - Increasing Transparency in Generic Drug Applications Act. S. 1214 - Retaining Access and Restoring Exclusivity Act. S. 1067 - Ensuring Timely Access to Generics Act. S. 935 - Fair Accountability and Innovative Research Drug Pricing Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 935
Protecting Health Care for All Patients Act of 2023
2023 · first_quarter · Firm: MCDERMOTT+ LLC
Prescription drug pricing issues. Implementation of the Inflation Reduction Act - Public Law No 117-69. H.R. 485 - the Protecting Health Care for All Patients Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 485
Source: Senate LDA